Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2007

  1. Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, Núm. 2, pp. 383-388